The IGF‐1R/mTOR pathway is frequently activated in sarcomas and other solid tumors, so it is considered an attractive target for Osteosarcoma (OS) and Ewing sarcoma (ES) since it represents the aggregation of multiple chemical and mechanical signaling mechanisms. This evidence concerns the gene MTOR and sarcoma.